Governance Iqvia Holdings Inc.

IQV

US46266C1053

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 21:10:00 18/06/2025 BST			5-day change	1st Jan Change
154.61 ^USD	+0.33%		-2.66%	-21.32%

06-17	Baird Adjusts Price Target on IQVIA Holdings to $159 From $161, Maintains Neutral Rating	MT
06-11	IQVIA Launches New AI Agents for Life Sciences and Healthcare	CI

Executive Committee: Iqvia Holdings Inc.

Manager

Positions heldSince

Ari Bousbib

64 year

Chief Executive Officer	02/10/2016
President	02/10/2016

James Berkshire

52 year

Chief Operating Officer	30/06/2017
Chief Tech/Sci/R&D Officer	-

Jeffrey Spaeder

Chief Tech/Sci/R&D Officer

Ronald Bruehlman

64 year

Director of Finance/CFO

31/07/2020

Eric Sherbet

60 year

General Counsel	28/02/2018
Corporate Secretary	-

W. Staub

62 year

Chief Tech/Sci/R&D Officer

24/09/2023

Trudy Stein

Human Resources Officer

02/10/2016

Karl Guenault

Chief Tech/Sci/R&D Officer

31/10/2017

Keriann Cherofsky

41 year

Comptroller/Controller/Auditor

31/07/2022

Composition of the Board of Directors: Iqvia Holdings Inc.

Director

CommitteesSince

Ari Bousbib

64 year

Audit Committee	14/06/2009
Finance Committee Chair	10/04/2013

Todd Sisitsky

53 year

Compensation Committee	31/03/2018
Governance Committee	31/03/2018
Nominating Committee	31/03/2018
Governance Committee Chair
Nominating Committee Chair
Executive Committee

John Danhakl

68 year

Compensation Committee Chair	31/12/1994
Nominating Committee Chair	31/12/1994
Compensation Committee
Governance Committee	31/05/2015
Nominating Committee	31/05/2015

Carol Burt

67 year

Governance Committee	31/10/2013
Nominating Committee	31/10/2013
Audit Committee Chair
Audit Committee	30/09/2019
Compensation Committee Chair

Colleen Goggins

69 year

Nominating Committee
Audit Committee	26/07/2017
Governance Committee Chair	26/07/2017
Nominating Committee Chair	26/07/2017

Sheila Stamps

67 year

Compensation Committee	14/12/2021
Governance Committee	14/12/2021
Nominating Committee	14/12/2021
Audit Committee	25/01/2022

John Leonard

67 year

Audit Committee	30/09/2016
Governance Committee	30/09/2016
Nominating Committee	30/09/2016

Leslie Morris

54 year

Governance Committee	23/01/2022
Nominating Committee	23/01/2022

John Connaughton

59 year

Compensation Committee

Jim Fasano

55 year

Audit Committee Chair

02/10/2016

Latest Appointments: Iqvia Holdings Inc.

Claritev Corporation Appoints Mohamed Ramzy as SVP and General Manager, International	05-28	CI
Terumo Blood and Cell Technologies Names Patrick Daly as Chief Business Officer	04-16	CI
Syneos Health Announces Chief Executive Officer Changes	09/10/24	CI
Iqvia Holdings Inc. Announces Transition of Kevin C. Knightly, President, Corporate Strategy and Enterprise Networks to Become A Senior Advisor to the Chief Executive Officer, Effective May 15, 2024	10/05/24	CI
IQVIA Holdings Inc. Appoints Richard Staub III President of Research & Development Solutions	26/09/23	CI
Iqvia Holdings Inc. Announces Resignation of Ronald A. Rittenmeyer as Member of the Board of Directors and Chairman of the Leadership Development and Compensation Committee	03/10/22	CI
Credit Suisse Initiates Coverage of 20 Companies in Life Science Tools, Services, Diagnostics Sectors; Outperform-Rated Bio-Rad, IQVIA, Bipo-Techne, Natera Named Top Picks	25/08/22	MT

More news

Former Officers and Directors: Iqvia Holdings Inc.

Insider

Positions held

SinceUntil

Kevin Knightly

Corporate Officer/Principal

14/05/2024

Costa Panagos

Chief Tech/Sci/R&D Officer

24/09/2023

Ronald Rittenmeyer

Director/Board Member	02/10/2016	01/10/2022
Independent Dir/Board Member	02/10/2016	01/10/2022

Tor Constantino

Public Communications Contact

31/07/2013

31/07/2022

Emmanuel N. Korakis

Comptroller/Controller/Auditor	31/10/2018	30/07/2022
Treasurer	-	30/07/2022

Jean Roberson

Director of Finance/CFO

30/06/2020

31/05/2022

Drayton Virkler

Corporate Officer/Principal

30/09/2011

31/08/2021

Nick Childs

Investor Relations Contact	31/03/2021	-
Public Communications Contact	31/03/2021	-
Treasurer	-	-

Jennifer Halchak

Investor Relations Contact

31/12/2018

31/12/2020

Michael McDonnell

Director of Finance/CFO

30/11/2015

30/07/2020

Michael J. Evanisko

Director/Board Member	30/04/2010	05/04/2020
Independent Dir/Board Member	30/04/2010	05/04/2020

Jonathan Coslet

Director/Board Member	31/12/2002	31/12/2019
Independent Dir/Board Member	31/12/2002	31/12/2019

Manav Dagar

Private Equity Investor

31/12/2018

30/10/2019

Donna Kralowetz

Director of Finance/CFO

30/04/2017

30/05/2019

Jack Greenberg

Director/Board Member	31/12/2003	31/03/2019
Independent Dir/Board Member	31/12/2003	31/03/2019

Charles Edward Williams

Comptroller/Controller/Auditor

31/10/2018

James Hanson

Corporate Officer/Principal

31/10/2017

31/05/2018

Benjamin Hughes

Corporate Officer/Principal

31/12/2013

28/02/2018

Richie Etwaru

Corporate Officer/Principal

31/03/2015

28/02/2018

James Erlinger

General Counsel	02/10/2016	27/02/2018
Corporate Secretary	02/10/2016	27/02/2018

Terry Murdock

Corporate Officer/Principal

31/08/2014

30/06/2017

Michael Stibilj

Corporate Officer/Principal

31/12/2014

31/05/2017

Marla Kessler

Public Communications Contact	30/09/2016	-
Sales & Marketing	30/09/2016	-

Kevin Gordon

Chief Operating Officer

30/09/2015

30/09/2016

Tal Rosenberg

Corporate Officer/Principal

30/09/2016

Darcie Peck

Investor Relations Contact	30/04/2002	31/10/2009
Corporate Officer/Principal	31/10/2009	31/01/2016

Lisa van Capelle

Human Resources Officer

31/12/2003

31/12/2015

Melissa Beelen

Corporate Officer/Principal

31/07/2010

31/10/2015

Fred Cohen

Director/Board Member

31/12/2006

31/10/2015

Michael Ackermann

Private Equity Investor

30/04/2009

31/10/2013

Christopher Katz

Consultant / Advisor

31/05/2010

30/07/2012

Thomas Pike

Director/Board Member	31/12/2011	-
Corporate Officer/Principal	31/12/2011	-

Daniel Barton

Corporate Officer/Principal

31/10/2011

Qiao Ling Lu

Corporate Officer/Principal

31/03/2006

31/07/2010

John Hernandez

Corporate Officer/Principal

31/12/1999

31/12/2000

David Hood

Corporate Officer/Principal

31/12/1992

31/12/1999

Gary Koch

Founder

31/12/1981

Edward Spaniel

General Counsel

Patrick Daly

Corporate Officer/Principal

Caroline Ruiz

Corporate Officer/Principal

Paul Kirchgraber

Chief Tech/Sci/R&D Officer

Melissa Schwarting

Public Communications Contact

Natalia Balko Kotchie

Corporate Officer/Principal

Christopher Gordon

Director/Board Member

Andrei Stoica

Corporate Officer/Principal

Margaret Keegan

Chief Tech/Sci/R&D Officer

Phil Bridges

Public Communications Contact

Andrew Markwick

Investor Relations Contact	-	-
Treasurer	-	-

Anand Kumaresh Tharmaratnam

President

Ibraheem Mahmood

Corporate Officer/Principal

Jon Resnick

Corporate Officer/Principal

Cynthia L. Verst

Corporate Officer/Principal

Bhavik Patel

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	14
Female	6

Of which Executive Committee

Male	7
Female	2

Of which Directors

Male	6
Female	4

Revisions

Revenue revisions (1 year)

Revenue revisions (4 months)

Revenue revisions (1 month)

EPS revisions (1 year)

EPS revisions (4 months)

ESG MSCI

ESG

Environment

Social

Governance

Controversy

Ethical controversies

Human rights controversies

Tax subsidies controversies

Sharia compliant

Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows: - development of contract research and clinical development solutions and services (55.4%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes; - development of technology and analytics solutions (39.9%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers; - integrated services (4.7%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc. Net sales are distributed geographically as follows: Americas (47.8%), Europe and Africa (31.9%) and Asia/Pacific (20.3%).

Employees

89,000

Sector

Biotechnology & Medical Research

Calendar

07-28 - Q2 2025 Earnings Release (Projected)

More about the company